List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 31 studies with search of:   "Bexarotene"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Bexarotene (targretin)
2 Recruiting Study of Tarceva and Targretin in Stage I-II Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: erlotinib (Tarceva) and bexarotene (Targretin)
3 Not yet recruiting Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Bexarotene
4 Recruiting BATTLE Program: Tarceva and Targretin in Patients With NSCLC
Condition: Lung Cancer
Interventions: Drug: Bexarotene;   Drug: Erlotinib
5 Recruiting Bexarotene Treatment in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: bexarotene (Targretin)
6 Recruiting Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Bexarotene
7 Terminated An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: vorinostat;   Drug: Comparator: bexarotene
8 Active, not recruiting Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: erlotinib and bexarotene
9 Completed Bexarotene With Narrow-Band UVB for Psoriasis
Condition: Psoriasis
Intervention: Drug: Bexarotene/NBUVB vs placebo NBUVB
10 Completed Study of Bexarotene in Patients With Acute Myeloid Leukemia
Conditions: AML;   Acute Myeloid Leukemia
Intervention: Drug: Bexarotene
11 Terminated Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis
Condition: Parapsoriasis
Intervention: Drug: Bexarotene 1% gel
12 Completed Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: bexarotene
13 Active, not recruiting Bexarotene in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: bexarotene
14 Active, not recruiting Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bexarotene;   Drug: recombinant interferon alfa
15 Recruiting Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: bexarotene;   Drug: capecitabine;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: tretinoin
16 Recruiting Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bexarotene;   Drug: pegylated liposomal doxorubicin hydrochloride
17 Recruiting Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
Condition: Lymphoma
Interventions: Drug: bexarotene;   Drug: methoxsalen;   Procedure: UV light therapy
18 Not yet recruiting Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
Conditions: Schizophrenia;   Schizoaffective Disorder;   Cognition
Interventions: Drug: Bexarotene;   Drug: Fenretinide;   Drug: Placebo
19 Recruiting Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: bexarotene;   Drug: sargramostim;   Procedure: biopsy;   Procedure: cytogenetic analysis;   Procedure: flow cytometry;   Procedure: fluorescence in situ hybridization;   Procedure: laboratory biomarker analysis
20 Completed Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Interventions: Drug: bexarotene;   Device: photopheresis

Previous Page Studies Shown (1-20) Next (21-31)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services